Dickinson Andrew D Insider Trades

Insider Trading History

Track insider trading activity for Dickinson Andrew D. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $22.6M 171,646 shares
Last Trade
Jun 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$376k 3,000 shares
$125.40
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $23M 174,646 shares
Last Trade
Jun 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$163k 1,341 shares
$121.48
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $23.2M 175,987 shares
Last Trade
Jun 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$340k 2,796 shares
$121.48
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $3.67M 27,851 shares
Last Trade
Jun 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$340k 2,796 shares
$121.48
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $22.8M 173,191 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$397k 3,000 shares
$132.27
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $23.2M 176,191 shares
Last Trade
Apr 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$423k 3,000 shares
$140.96
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $23.6M 179,191 shares
Last Trade
Mar 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$433k 3,000 shares
$144.23
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $24.4M 185,338 shares
Last Trade
Mar 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$961k 6,469 shares
$148.56
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $24M 182,191 shares
Last Trade
Mar 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$468k 3,147 shares
$148.56
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $2.77M 21,057 shares
Last Trade
Mar 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$961k 6,469 shares
$148.56
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $4.73M 35,880 shares
Last Trade
Mar 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.76M 45,470 shares
$148.56
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $23.6M 178,869 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.65M 11,090 shares
$148.95
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $22.1M 167,779 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$463k 3,000 shares
$154.43
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $25.7M 195,370 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.41M 44,867 shares
$142.89
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $22.5M 170,568 shares
Last Trade
Feb 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.55M 24,802 shares
$143.28
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $19.8M 150,503 shares
Last Trade
Jan 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$373k 3,000 shares
$124.31
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $20.2M 153,503 shares
Last Trade
Dec 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$366k 3,000 shares
$122.00
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $20.8M 158,248 shares
Last Trade
Dec 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$448k 3,693 shares
$121.37
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $20.6M 156,503 shares
Last Trade
Dec 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$212k 1,745 shares
$121.34
$131.70
Gilead Sciences
Gilead Sciences GILD
Chief Financial Officer
Holding Value $3.63M 27,526 shares
Last Trade
Dec 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$448k 3,693 shares
$121.37
$131.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up